Shareholder plans sale of 5,190 common shares

A shareholder has filed a notice of intent to sell 5,190 shares of common stock through Fidelity Brokerage Services LLC on or about 01/09/2026, with trading on the NASDAQ exchange.

Rhea-AI Filing Summary

A shareholder has filed a notice of intent to sell 5,190 shares of common stock through Fidelity Brokerage Services LLC on or about 01/09/2026, with trading on the NASDAQ exchange. The shares have an aggregate market value of $5,557.45 based on the information provided and are part of a total of 115,352,289 shares outstanding. These securities were acquired from the issuer on 01/08/2026 through restricted stock vesting as compensation, with the same date shown for acquisition and payment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144-related filing for FATE indicate?

It indicates that a shareholder plans to sell 5,190 shares of common stock on NASDAQ through Fidelity Brokerage Services LLC, with an aggregate market value of $5,557.45.

How many FATE shares are planned to be sold and on which exchange?

The notice covers 5,190 shares of common stock, with trading indicated for the NASDAQ exchange.

When and how were the FATE shares to be sold originally acquired?

The 5,190 shares were acquired on 01/08/2026 from the issuer through restricted stock vesting as compensation.

What is the reported market value of the FATE shares covered by this notice?

The filing lists an aggregate market value of $5,557.45 for the 5,190 common shares to be sold.

How many FATE shares are outstanding according to this filing excerpt?

The table states that there are 115,352,289 shares of the issuer’s common stock outstanding.

Who is the broker for the planned FATE share sale?

The notice identifies Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 03:08 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001748177
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FATE THERAPEUTICS INC
SEC File Number	001-36076
Address of Issuer	12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CALIFORNIA 92131
Phone	858.875.1803
Name of Person for Whose Account the Securities are To Be Sold	Valamehr Bahram
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5190	5557.45	115352289	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/08/2026	Restricted Stock Vesting	Issuer			5190	01/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Bahram Valamehr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)